Skip to content
Open access

Fibroblasts resist Staphylococcus aureus on the skin surface by responding to interleukin-1 and recruiting neutrophils

Aug 2026 · Science Advances · Vol 12 · 0 citations · 98 references
Medicine

TL;DR

It is found that fibroblast recognition of interleukin-1 is essential for immune response and fibroblasts actively participate in innate immunity and highlight an IL-1R1–dependent keratinocyte-fibroblast-neutrophil axis of communication.

Abstract

Staphylococcus aureus can cause serious infections, yet it can also reside on the skin without causing disease. This apparent paradox implies a strong host defense system, which prevents S. aureus from invading the dermis. In this study, we investigate how the skin detects and responds to superficial S. aureus exposure. Using unbiased transcriptomic, biochemical, and phosphoproteomic analyses, followed by targeted validation in human and mouse models, we found that fibroblast recognition of interleukin-1 is essential for immune response. Deletion or blockade of the interleukin-1 receptor type 1 (IL-1R1) in fibroblasts in vitro abolished keratinocyte-driven changes in gene expression and reduced chemokine production. Furthermore, the skin of mice lacking fibroblast IL-1R1 had fewer neutrophils and higher bacterial load after topical S. aureus application. These findings show that fibroblasts actively participate in innate immunity and highlight an IL-1R1–dependent keratinocyte-fibroblast-neutrophil axis of communication. Understanding this pathway provides insights into mechanisms that initiate neutrophil recruitment to the skin and may help develop new approaches to therapy.

Read PDF

Similar papers

Open access Aug 2026

Innate host defense lysozyme may help control Staphylococcus aureus in atopic dermatitis

Findings suggest that AD patients may respond to cutaneous S. aureus colonization by upregulating lysozyme production, suggesting the possible involvement of the host lysozyme-mediated innate immune response in helping to control S. aureus burden in AD patients.

P. Schlievert, S. Kilgore, E. Berdyshev et al. · 0 citations
Review Open access Aug 2026

Mast Cells in Host Defense Against Cutaneous Staphylococcus aureus Infection

The role of mast cells is discussed in three models of S. aureus skin infection according to skin depth: epicutaneous sensitization, intradermal injections, and subcutaneous injections to encourage deeper investigation and inform the development of immunomodulatory-based therapeutics.

Hannah Dychtenberg, Carly Kadonoff, Bailey Lehnert et al. · 0 citations
Jul 2026

The C-type lectin receptor Mincle is functionally expressed by murine bone cells and can mediate inflammatory responses to Staphylococcus aureus 2257334

It is shown that bone cells functionally express Mincle and indicated that this C-type lectin can mediate, at least in part, the inflammatory responses of OBs to SA challenge, which are attenuated following Mincle blockade.

Erin L. Mills, Quinton A. Krueger, Aiza Noyal et al. · 0 citations
Jul 2026

Gene-Specific Rewiring of Type I Interferon Responses by Staphylococcus aureus 2329926

The findings suggest that S. aureus alters activation of the canonical type I IFN-mediated Jak-STAT pathway through suppression of STAT1 activation and altering chromatin remodeling and may alter the host response to this pathogen in a context-dependent manner and contribute to difficulty in clearing S. aureus infectio...

Qiong Zhang, Ruoxi Yuan, Lionel B Ivashkiv · 0 citations
Open access Jan 2026

Will It Be Possible in the Future to Target Innate Immunity Against Staphylococcus aureus Using Resident Microbiota and Plant Extracts?

Test the hypothesis that plant extracts trigger the gentle release of staphylococcal bioactive components that can modulate innate immunity and presents V. opulus extracts as the triggers to release bioactive components from S. aureus cells, able to target innate immunity against staphylococci, which may be used in the...

Urszula Wójcik-Bojek, Joanna Rywaniak, Beata Sadowska · 0 citations
Open access Jul 2026

Neutrophil Reprogramming Fuels Immunosuppression in Staphylococcus aureus Biofilm Infection 2256977

This findings reveal that S. aureus biofilms exploit TLR2-MyD88 signaling to reprogram neutrophils into immunosuppressive G-MDSC-like cells, which highlights both bacterial-derived TLR2 ligands and host TLR2 signaling as promising therapeutic targets to restore antimicrobial immunity in neurosurgical infections.

A. Ogunware, Gunjan Kak, Tammy Kielian et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.